GGenetics Read More Genetic modification enhances “living drugs” for blood cancers25 September 2025 CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in…
GGenetics Read More Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use15 September 2025 New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…